Far East Orchard Limited

O10.SI : Singapore Exchange

1.030

+1.98%

Share Price in SGD. As of 20 Sep 17:04:46 SGT

All

Chart

Key stats

Far East Orchard Limited’s share price has increased by 0.0% over the past 1 year. It has underperformed the Singapore stock market during this period.

Share Price Performance
52 Week Range
SGD 0.975 - 1.060
Price vs 5-year high/low
Near high
O10.SI Market
1 Month 3.0% 7.5%
YTD 1.0% 12.2%
1 Year 0.0% 18.0%
5 Year -11.2% 13.5%
Valuation
Financial
Dividend

Recently happened to Far East Orchard Limited

Far East Orchard Limited has announced 1Q FY2024 Results Summary.

Earnings

View earnings highlights
Beansprout Analysis
Market Analysis

Analyst Ratings

There is no analyst rating data currently available for Far East Orchard Limited.

Valuation
Earnings
Financials
News
Profile

Company Description

Far East Orchard Limited is a real estate company with a lodging platform that aims to achieve sustainable and recurring income through a diversified and balanced portfolio. Established since 1967, Far East Orchard has a track record in real estate development, investment and management across residential, commercial, hospitality and PBSA properties in Australia, Japan, Malaysia, Singapore, and the UK. Listed on the Mainboard of the Singapore Exchange, Far East Orchard is also a member of Far East Organization, Singapore’s largest private property developer.

Redefining itself through a strategic business transformation in 2012, Far East Orchard expanded into hospitality management business and invested in healthcare real estate. In 2015, it further diversified its real estate portfolio to include PBSA properties development and investment in the UK. In 2023, Far East Orchard celebrated its 10-year partnerships in the hospitality business with The Straits Trading Company Limited and Toga Group, Australia. 

Far East Orchard’s hospitality arm, Far East Hospitality, together with the joint venture, TFE hotels, now owns over 10 assets and manages close to 100 properties with more than 16,600 rooms in Australia, Austria, Denmark, Germany, Hungary, Japan, Malaysia, New Zealand, Singapore, and Switzerland, featuring 10 distinct brands. Far East Orchard’s PBSA portfolio includes 3,687 beds across key cities in the UK. In 2022, Far East Orchard entered into a joint venture development in Bristol for the development of a 706- bed PBSA asset. With the joint venture development in Bristol and announced site development in Glasgow, totalling 979 beds, the Group’s total PBSA portfolio will grow to approximately 4,700 beds across 15 properties in the UK upon completion of the developments. Additionally, the Group holds a portfolio of purpose-built medical suites for lease and sale in Novena, Singapore’s premier medical hub.